WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004035002) BENZOPYRANONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS FOR TREATING OR PREVENTING CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/035002    International Application No.:    PCT/US2003/032932
Publication Date: 29.04.2004 International Filing Date: 15.10.2003
Chapter 2 Demand Filed:    14.05.2004    
IPC:
A61K 31/40 (2006.01), A61K 31/4025 (2006.01), C07D 405/02 (2006.01)
Applicants: SIGNAL PHARMACEUTICALS, LLC [US/US]; 4550 Towne Centre Court, San Diego, CA 92121 (US) (For All Designated States Except US).
FRIEDMAN, Glenn [US/US]; (US) (For US Only).
MCKIE, Jeffrey [US/US]; (US) (For US Only).
WRIGHT, Jonathan [US/US]; (US) (For US Only)
Inventors: FRIEDMAN, Glenn; (US).
MCKIE, Jeffrey; (US).
WRIGHT, Jonathan; (US)
Agent: INSOGNA, Anthony, M.; Jones Day, 222 East 41st Street, New York, NY 10017 (US)
Priority Data:
60/418,469 15.10.2002 US
10/685,722 14.10.2003 US
Title (EN) BENZOPYRANONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS FOR TREATING OR PREVENTING CANCER
(FR) COMPOSES DE BENZOPYRANONE, COMPOSITIONS CORRESPONDANTES ET METHODES DE TRAITEMENT OU DE PREVENTION DU CANCER
Abstract: front page image
(EN)This invention relates to Benzopyranone Compounds, compositions comprising a Benzopyranone Compound and methods for treating or preventing cancer or inhibiting the growth of a cancer cell or neoplastic cell comprising administering an effective amount of a Benzopyranone Compound. The Benzopyranone Compounds have the formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 is halogen, trifluoromethyl or C1-6 alkyl.
(FR)L'invention concerne des composés de benzopyranone, des compositions comprenant un composé de benzopyranone, ainsi que des méthodes destinées à traiter ou prévenir le cancer ou à inhiber la croissance d'une cellule cancéreuse ou néoplasique, et consistant à administrer une dose efficace d'un composé de benzopyranone. Lesdits composés de benzopyranone sont représentés par la formule (I), dans laquelle R1 est halogène, trifluorométhyle ou alkyle C1-6. L'invention concerne également un sel pharmaceutiquement acceptable de ces composés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)